powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1356860290
Kamal Al-Eryani
DDS, PHD
Maxillofacial Surgery
San Francisco,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
642
Beneficiaries
—
Total drug cost
$17K
Distinct drugs
13
Brand share
10.4%
Top prescribed drugs
Clotrimazole
190 claims
Dexamethasone
142 claims
Chlorhexidine Gluconate
76 claims
Clobetasol Propionate
40 claims
Lidocaine Hcl
34 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
81.1
Cost
71.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.42%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
463
Unique beneficiaries
—
Total services
650
Distinct HCPCS
8
Medicare payment
$53K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 31 Maxillofacial Surgery providers in CA — top quintile (cohort median 96).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.